Brii B
Brii B, officially known as Brii Biosciences, is a prominent biopharmaceutical company headquartered in China (CN). Founded in 2017, the company has rapidly established itself in the global healthcare landscape, focusing on innovative therapies for infectious diseases and other serious health conditions. With a strong operational presence in both China and the United States, Brii B is dedicated to advancing the development of novel treatments. The company’s core offerings include monoclonal antibodies and antiviral therapies, distinguished by their cutting-edge research and development processes. Brii B has achieved significant milestones, including strategic partnerships and successful clinical trials, positioning itself as a leader in the biopharmaceutical industry. With a commitment to improving patient outcomes, Brii B continues to make strides in addressing unmet medical needs on a global scale.
DitchCarbon Score
How does Brii B's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Brii B's score of 5 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Brii B's reported carbon emissions
In 2023, Brii B reported total carbon emissions of approximately 68,670 kg CO2e, all of which were classified under Scope 2 emissions, indicating that these emissions were primarily associated with purchased electricity. This represents a significant reduction from 2022, where emissions totalled about 80,480 kg CO2e, also entirely from Scope 2. In 2021, Brii B's total emissions were about 125,640 kg CO2e, showcasing a downward trend in their carbon footprint over the years. The company has not disclosed any specific reduction targets or initiatives, nor have they committed to any climate pledges or SBTi (Science Based Targets initiative) targets. Brii B's emissions intensity metrics indicate a focus on improving efficiency, with reported electricity consumption intensity per employee of approximately 1.72 in 2023 and 1.82 in 2022. This suggests ongoing efforts to enhance operational sustainability, although specific reduction initiatives have not been outlined. Overall, Brii B's commitment to reducing its carbon emissions is evident through its decreasing emissions figures, although further transparency regarding specific targets and initiatives would strengthen its climate commitment narrative.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | 80,480 | 00,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Brii B is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
